SPONSOR
National Cancer Centre, Singapore
Total Trials
4
Recruiting
4
Phases
Phase 2
Conditions studied: Solid TumorHepatocellular CarcinomaHormone Receptor-Positive HER2-Negative Advanced Breast Cancer
National Cancer Centre, Singapore is a clinical research sponsor with 4 registered studies on ClinicalTrials.gov, of which 4 are actively recruiting participants. Research covers conditions including Solid Tumor, Hepatocellular Carcinoma, Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Cancer Centre, Singapore
How many clinical trials has National Cancer Centre, Singapore sponsored?
ClinicalMetric currently tracks 4 clinical trials sponsored by National Cancer Centre, Singapore, of which 4 are actively recruiting participants. These trials cover conditions including Solid Tumor, Hepatocellular Carcinoma, Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Cancer Centre, Singapore research focus on?
National Cancer Centre, Singapore clinical trials span Solid Tumor, Hepatocellular Carcinoma, Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Cancer Centre, Singapore clinical trial?
To participate in a National Cancer Centre, Singapore trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Cancer Centre, Singapore trials with current recruitment status updated daily.
Clinical Trials by National Cancer Centre, Singapore
NCT06956248
Recruiting
Innovating Access to Novel Therapies Through Standardized Prospective Integration of Response Evaluations (IMPACT-INSPIRE)
Solid Tumor
NCT05516628 Phase 2
Recruiting
Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma
Hepatocellular Carcinoma
NCT02806388
Recruiting
Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project
Solid Tumor
NCT05286437 Phase 2
Recruiting
Phase II Lenvatinib and Pembrolizumab in Endocrine Resistant Breast Cancer With Letrozole
Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology